<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04686981</url>
  </required_header>
  <id_info>
    <org_study_id>20283-0-01</org_study_id>
    <nct_id>NCT04686981</nct_id>
  </id_info>
  <brief_title>Endovascular thromBectomy of Acute Mesentery Vessels Occlusion Hybrid With Emergent Laparoscopic Surgery</brief_title>
  <acronym>BOWEL</acronym>
  <official_title>Vascular Surgery Department of Beijing Tsinghua Chang Gung Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tsinghua Chang Gung Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tsinghua Chang Gung Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute mesenteric artery thromboembolism(AMT) is one of the important causes of acute abdomen&#xD;
      and intestinal necrosis. If the intestinal blood supply is not restore in time, the prognosis&#xD;
      of the disease is often poor and even endangers the life of the patient. Through laparoscopic&#xD;
      surgery combined with modern minimally invasive endovascular technology, the blood supply of&#xD;
      patients' intestine is restored. Observe the perioperative vascular patency rate, all-cause&#xD;
      mortality, and the probability of short bowel syndrome. Through the hybrid operating room, we&#xD;
      want to seek a multidisciplinary collaborative treatment mode to improve the long-term&#xD;
      survival rate of such patients with enough intestines and completely free from TPN, and&#xD;
      improve the prognosis of these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a clinical cohort study; consecutively registered 30 patients with acute&#xD;
      abdomen caused by superior mesenteric artery thromboembolism. All patients underwent&#xD;
      laparoscopy to explore the intestinal blood supply and whether there was intestinal necrosis.&#xD;
      If intestinal necrosis occurs, we will perform open surgery, mesenteric artery embolectomy&#xD;
      and necrotic bowel resection, Intestinal fistula. If there is no intestinal necrosis,&#xD;
      minimally invasive intravascular thrombus aspiration treatment will be performed, and a&#xD;
      second laparoscopy is performed after the operation to determine whether the intestinal blood&#xD;
      supply is improved.&#xD;
&#xD;
      The main endpoints are the survival rate of bowel function preserved at 30 days, and the&#xD;
      secondary endpoints: mortality, short bowel syndrome rate, and open surgery rate. The&#xD;
      secondary observations were the success rate of end-point vascular patency, the rate of&#xD;
      transition to laparotomy, the 30-day and long-term patency rate of blood vessels.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Months</target_duration>
  <primary_outcome>
    <measure>survival rate with preserved bowel function</measure>
    <time_frame>within 30 days after operations</time_frame>
    <description>Counting data</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence of all-cause mortality</measure>
    <time_frame>within 30 days after operations</time_frame>
    <description>Counting data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vascular patency rate</measure>
    <time_frame>180 days after operations</time_frame>
    <description>Counting data</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Mesenteric Artery Ischemia</condition>
  <condition>Thromboembolism</condition>
  <arm_group>
    <arm_group_label>mesenteric artery thromboembolism patients without intestinal necrosis</arm_group_label>
    <description>After laparoscopic exploration, If there is no intestinal necrosis, minimally invasive intravascular thrombus aspiration treatment will be performed,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mesenteric artery thromboembolism patients with intestinal necrosis</arm_group_label>
    <description>After laparoscopic exploration, If intestinal necrosis occurs, open surgery, mesenteric artery embolectomy and necrotic bowel resection, intestine fistula will be performed.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        the patients suffering from superior mesenteric artery thromboembolism&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with intestinal ischemia and acute abdomen pain caused by superior mesenteric&#xD;
             artery thromboembolism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intestinal ischemia patients who have been infected with toxic shock and unstable&#xD;
             circulation;&#xD;
&#xD;
          -  Those who have acute large-area myocardial infarction, large-area cerebral infarction,&#xD;
             or have serious heart failure or sequelae of cerebral infarction within 1 month;&#xD;
&#xD;
          -  Combined with portal hypertension, gastrointestinal hemorrhage, portal and mesenteric&#xD;
             venous reflux obstruction diseases;&#xD;
&#xD;
          -  Contrast agent allergy, severe renal insufficiency, and inability to perform&#xD;
             intravascular surgery;&#xD;
&#xD;
          -  Patients with severe cardiopulmonary disease, uncontrollable hypertension and other&#xD;
             poor surgical tolerance;&#xD;
&#xD;
          -  Patients with advanced malignant tumors with intestinal obstruction or life expectancy&#xD;
             &lt;2 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>sifan yang</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Tsinghua Chang Gung Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>keqiang zhao, M.D.</last_name>
    <phone>0086-010-56118962</phone>
    <email>zkqiang@btch.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>weiwei wu, M.D.</last_name>
    <phone>0086-010-56118899</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Tsinghua Chang Gung Hosipital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>102218</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sifan Yang, M.D.</last_name>
      <phone>0086-56113627</phone>
      <email>ysf19900505@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 16, 2020</study_first_submitted>
  <study_first_submitted_qc>December 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2020</study_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tsinghua Chang Gung Hospital</investigator_affiliation>
    <investigator_full_name>Weiwei Wu</investigator_full_name>
    <investigator_title>Department director</investigator_title>
  </responsible_party>
  <keyword>Acute mesenteric artery thrombosis</keyword>
  <keyword>Hybrid operation</keyword>
  <keyword>Mechanical thrombectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

